Article
Cancer Stem Cells (CSCs) as a Rational Therapeutic Cancer Target, and Screening for CSC-targeting Drugs.
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan - 1 Jan 2017
Mashima Tetsuo
Abstract excerpt
The emergence of drug resistance is a major obstacle to the successful pharmacological treatment of cancer. Tumor heterogeneity is one of the key factors underlying drug resistance. Cancer cell heterogeneity in tumors is caused by genetic mutation and by the existence of cancer stem cells (CSCs). CSCs are defined as a subpopulation of highly tumorigenic cancer cells with self-renewal activity. It has been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
